Skip to main content
Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
17.87
+0.07 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed

Avanos Medical Revenue

Avanos Medical had revenue of $170.40M in the quarter ending September 30, 2024, a decrease of -0.53%. This brings the company's revenue in the last twelve months to $681.50M, down -0.01% year-over-year. In the year 2023, Avanos Medical had annual revenue of $673.30M, down -1.58%.

Revenue (ttm)
$681.50M
Revenue Growth
-0.01%
P/S Ratio
1.21
Revenue / Employee
$180,721
Employees
3,771
Market Cap
771.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023673.30M-10.80M-1.58%
Dec 31, 2022684.10M97.10M16.54%
Dec 31, 2021587.00M-127.80M-17.88%
Dec 31, 2020714.80M17.20M2.47%
Dec 31, 2019697.60M45.30M6.94%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Castle Biosciences 311.88M
Cytek Biosciences 201.21M
Avid Bioservices 142.36M
Cronos Group 111.23M
AbCellera Biologics 32.96M
Autolus Therapeutics 10.09M
Relay Therapeutics 10.01M
Revenue Rankings

AVNS News

More News